Search projects

GNA NOW

Novel Gram-negative antibiotic now

Keywords: IMI project Antimicrobial resistance Infectious diseases AMR Accelerator Conducting clinical trials

9

Impentri

Development of Impentri, an intravenous imatinib formulation for COVID-19 acute respiratory distress syndrome (ARDS)

Keywords: IMI project Respiratory diseases Infectious diseases Coronaviruses Conducting clinical trials

10

ND4BB Translocation

Keywords: IMI project Antimicrobial resistance Infectious diseases ND4BB Clinical trial design Conducting clinical trials Clinical networks Real-world data, evidence Drug discovery Economic model

11

PERISCOPE

PERtussIS COrrelates of Protection Europe

Keywords: IMI project Infectious diseases Vaccines Conducting clinical trials

12

RespiriNTM

Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs

Keywords: IMI project Antimicrobial resistance Infectious diseases AMR Accelerator Conducting clinical trials Target identification

13

RespiriTB

Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors

Keywords: IMI project Antimicrobial resistance Infectious diseases AMR Accelerator Conducting clinical trials

14

TRIC-TB

Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments

Keywords: IMI project Antimicrobial resistance Infectious diseases AMR Accelerator Conducting clinical trials

15

iABC

Inhaled antibiotics in bronchiectasis and cystic fibrosis

Keywords: IMI project Antimicrobial resistance Infectious diseases ND4BB Clinical trial design Conducting clinical trials Biobanks Clinical networks Drug delivery

16